Lam Research stock swings on tariff jitters as UBS lifts target ahead of earnings

Lam Research stock swings on tariff jitters as UBS lifts target ahead of earnings

New York, Jan 20, 2026, 18:51 EST — After-hours

  • Lam Research closed the regular session down 0.25%, with little movement in after-hours trading
  • Tech shares dipped after renewed tariff warnings rattled the market, stirring volatility among chipmakers
  • UBS lifted its price target for Lam, as investors look ahead to the Jan. 28 earnings report for guidance

Lam Research Corp shares slipped roughly 0.2% in after-hours trading Tuesday, holding close to $222 following a choppy session that ended with little change. 1

The chip-equipment maker faces a crucial week, with political tensions shaping risk appetite and its earnings report due in eight days. Lam has announced its quarterly financial conference call will take place on Jan. 28. 2

The date is crucial since Lam provides wafer fabrication equipment—key tools for chip production—and investors often interpret its outlook as a gauge of chipmakers’ appetite for new plants and upgrades.

Wall Street stumbled Tuesday, hit by concerns over U.S. President Donald Trump’s tariff threats targeting Europe. The news spooked investors, driving them away from riskier assets and dragging down tech-focused indexes. 3

Trump announced that an extra 10% tariff will kick in on Feb. 1 for products from eight European nations, linking the measure to his bid for U.S. control over Greenland. 4

Lam’s decline was relatively mild compared to others in the sector. Applied Materials slid 2.7%, while inspection-tool specialist KLA tumbled 5.2% during the regular session, MarketWatch data shows. 5

UBS gave bulls a boost, lifting its price target on Lam to $255 from $200 while maintaining a “Buy” rating. The firm cited ongoing checks that suggest a solid Q2 performance and an optimistic guidance outlook. 6

Shares swung between roughly $217.61 and $226.15 on Tuesday, finally closing close to $222. 1

A lot can go sideways. A prolonged trade dispute might freeze budgets and throw supply chains into chaos, while even a robust chip cycle can stumble if customers delay their orders. “Geopolitical tensions have dented sentiment and cooled early-year exuberance,” said Nuveen strategist Laura Cooper. 7

Investors are keeping an eye on whether the tariff dispute will escalate into wider policy battles, as markets monitor the legal and political fallout from Trump’s trade moves. 8

Lam’s earnings report and conference call on Jan. 28 will be key. Investors will be listening closely for any shifts in management’s outlook on demand, delivery schedules, and customer spending. This could reshape forecasts for the stock. 2

Stock Market Today

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
GE Vernova stock closes up nearly 6% — what to watch before Monday’s trade

GE Vernova stock closes up nearly 6% — what to watch before Monday’s trade

7 February 2026
GE Vernova shares jumped 5.6% to $779.35 Friday as Wall Street rallied and the company reported 1.1 GW of U.S. wind repower orders for 2025. The company also closed its $5.3 billion purchase of the remaining Prolec GE stake and completed a $2.6 billion senior notes offering. Investors await next week’s U.S. jobs and inflation data.
Citi stock jumps 6% as consent-order exit talk builds — what to watch next week

Citi stock jumps 6% as consent-order exit talk builds — what to watch next week

7 February 2026
Citigroup shares rose 6% to $122.69 at Friday’s close after a Reuters report said executives are more optimistic about completing key consent orders this year. Citi also announced a $2.3 billion preferred stock redemption and a matching program for employee “Trump Accounts.” Investors await next week’s U.S. economic data and Citi conference appearances.
Eli Lilly stock ticks up after FDA “breakthrough” tag for ovarian cancer drug
Previous Story

Eli Lilly stock ticks up after FDA “breakthrough” tag for ovarian cancer drug

Coinbase stock drops after hours as bitcoin slides; Armstrong keeps crypto bill push alive in Davos
Next Story

Coinbase stock drops after hours as bitcoin slides; Armstrong keeps crypto bill push alive in Davos

Go toTop